凝血分析仪市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00008957
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 205
Buy Now

【研究报告】凝血分析仪市场规模预计将从2022年的41.8371亿美元增长到2030年的66.9008亿美元;预计 2022 年至 2030 年复合年增长率为 6.0%。

分析师观点

凝血分析仪市场分析包括驱动因素,例如血液疾病患病率上升等人口和心血管疾病发病率的增加。此外,即时检测凝血分析仪是 2022 年至 2030 年市场增长的未来趋势。根据报告中的细分,从产品类型细分来看,临床实验室分析仪细分市场在2020年占据了最大份额。从测试类型来看,二维凝血酶原时间测试细分市场占据了最大份额。从技术角度来看,光学技术领域将在凝血分析仪中占据相当大的份额,从而在预测期内主导市场增长。根据应用情况,预计临床实验室领域将在 2022 年至 2030 年期间占据凝血分析仪市场增长的最大份额。

凝血分析仪可快速、简单地测量血小板水平。凝血分析仪用于测量凝血途径速度,在几分钟内检查凝血酶和凝血活酶水平。此外,几家顶级公司正在制造用于止血测试的创新凝血分析仪。 Sysmex CS-2500 系统就是这样的一个例子,它采用了巧妙设计的技术,包括使用 PSI 技术进行基于测定的分析前样品质量检查、自动混合研究、自动血小板聚集和凝块波形分析。这种自动化流程提高了效率、卓越的准确性和可靠的首次运行结果。

战略洞察

市场洞察

血液疾病患病率上升

凝血分析仪是测量和评估血块形成或血块凝固速度的设备。它提供了一种快速、简单的方法来准确测量血小板水平以及凝血酶和凝血活酶水平。根据国家罕见疾病组织的资料,A 型血友病是一种常见的 X 连锁隐性遗传病,也是继冯·维勒布兰德病之后第二常见的遗传性凝血因子缺乏症。在美国,大约每 5,000 名新生儿男性中就有 1 人患有 A 型血友病。根据国家医学图书馆 (NLM) 的数据,2020 年,美国大约有 30,000-33,000 名男性患有血友病。据美国卫生与公众服务部称,2020 年,约 10 万美国人患有镰状细胞病 (SCD),这是最常见的遗传性血液疾病。此外,到 2050 年,患有 SCD 的人数预计将增加约 30%。根据国家医学图书馆的数据,到 2022 年,约 1% 的个体(未选择的人群)患有冯维勒布兰德病,即每 100 万人中有 125 人患有血管性血友病。同样,根据 2020 年在 NLM 上发表的研究,在欧盟,有 8000 万人患有从癌症到出血性疾病等血液疾病。根据国家罕见疾病组织的数据,2022 年,在美国,免疫性血小板减少症 (ITP)一种自身免疫性出血性疾病,每年每 100 万人中约有 66 名成年人受到影响。此外,在美国,成人 ITP 的发病率为每年每 10 万人中约 3.3 例,而患病率为每 10 万人中 9.5 例。因此,血液疾病的患病率日益增加正在推动凝血分析仪市场的增长。

床旁护理 (POC) 凝血分析仪的开发

快速、可靠的评估对于有外伤或其他出血问题的患者来说,止血至关重要。由于样品制备和分析过程的要求,常规凝血试验无法可视化凝块形成过程,只能在30-90分钟后得出结果。粘弹性凝血测试、血小板功能测试、血气分析和其他凝血计等即时护理 (POC) 设备可用于评估止血效果。 POC测量工具可作为医院内部和外部的决策和管理工具。当时间至关重要时,POC 分析仪可以在急诊室、冠心病监护室、手术室和手术室提供即时、可操作的结果。除了门诊诊所和医生办公室外,这些设备还可以协助药房、护理中心和患者家中的患者管理。 POC 凝血分析仪可及时提供结果,且不会影响中心实验室提供的诊断质量控制。在POC测试中,重要的是要快速提供结果,同时保证准确性和质量。

2021年,西门子Healthineers推出了全自动CN-3000和CN-6000系统,这是中高端的系统。 -大容量手持式POC凝血测试设备。西门子 Healthineers 的 Xprecia Stride 凝血分析仪已获得 FDA 批准作为 POC 凝血分析仪设备。该设备已证明 PT/INR(即凝血酶原时间/国际标准化比值)测试性能与罗氏 CoaguChek XS 相当。

因此,POC 凝血分析仪的不断发展可能会推动该市场的增长。预测期。

报告细分和范围

基于产品类型的见解

根据产品类型,凝血分析仪市场细分为临床实验室分析仪和即时检测分析仪。临床实验室分析仪进一步分为系统和消耗品。到 2022 年,临床实验室分析仪细分市场将占据更大的市场份额。即时检测分析仪在凝血分析仪市场中占据显着的复合年增长率。护理点 (POC) 测试分析仪用于获取血液蛋白的结果。这些分析仪用于医生办公室、医院。 POCT 测试分析仪可提供多项医学测试的快速反馈。

POCT 的优点

便携性方便速度连接样本质量质量保证这些设备可测量凝血的电化学、光学和机械参数。凝血监测的 POC 测试在各种激活剂的帮助下,在检测出血性疾病和监测抗凝药物方面发挥着重要作用。在这方面,微流控、荧光显微镜、电化学传感、光声检测和微/纳米机电系统等先进技术已被用来开发高精度、稳健且具有成本效益的POC设备,例如罗氏诊断 CoaguChek XS 系统和爱科来 SPOTCHEM HS HS-7710。

基于测试类型的见解

根据测试类型,全球凝血分析仪市场是隔离的包括凝血酶原时间测试、纤维蛋白原测试、D-二聚体测试、血小板功能测试、活化凝血时间测试、活化部分凝血活酶时间测试等。凝血酶原时间测试领域在 2022 年占据最大的市场份额。D-二聚体测试领域预计在预测期内将以最高复合年增长率增长。凝血酶原时间 (PT) 是一项用于帮助检测和诊断出血性疾病或过度凝血疾病的测试;国际标准化比率根据 PT 结果计算得出,用于监测血液稀释药物(抗凝剂)华法林 (Coumadin) 预防血栓的作用。

PT 测量所需的秒数添加物质(试剂)后血液样本中形成凝块。 PT 通常与部分凝血活酶时间 (PTT) 一起进行,它们一起评估称为凝血因子的蛋白质的数量和功能,凝血因子是正常血栓形成的重要组成部分。

PT 和 INR当一个人被处方服用抗凝药物华法林时,会定期进行检查,以确保该药物产生预期的效果。

同样,D-二聚体测试也用于帮助排除这种情况的存在不适当的血凝块(血栓)。 D-二聚体测试用于帮助排除的一些病症包括深静脉血栓形成、中风和肺栓塞。该测试可用于诊断导致高凝状态(一种不适当凝血的倾向)的疾病和病症。 D-二聚体水平还可用于帮助诊断弥散性血管内凝血 (DIC) 并监测 DIC 治疗的有效性。

D-二聚体是血栓形成时产生的蛋白质片段之一。溶解在体内。除非身体正在形成和分解血栓,否则它通常无法检测到或在非常低的水平下可检测到。然后,它在血液中的水平会显着升高。该测试检测血液中的D-二聚体。

基于技术的见解

从技术角度来看,凝血分析仪市场分为光学技术、机械技术、电化学技术, 和别的。到 2022 年,光学技术领域将占据最大的凝血分析仪市场份额。光学凝血分析仪与测试试剂一起使用,可提供快速的实验室质量结果,支持心脏病学、外科和重症监护的临床决策。万孚的即时检测(POCT)凝血分析仪是第一款可以测试PT/INR/APTT、TT、FIB和ACT的仪器。同样,可以通过光散射或光透射研究其光学特性来监测血液的粘弹性特性。在激光散斑流变仪中,血液中布朗运动引起的光散射可提供有关血液粘弹性或凝固的直接信息。为了测量这一点,当用激光照射凝固的血液时,通过从一系列图像帧中找到自相关曲线来测量随时间变化的斑点强度波动。 LSR 方法还建议实时快速评估抗凝状态。

基于应用的见解

按应用,市场分为临床实验室、医院等。临床实验室领域在 2022 年占据最高的市场份额,并将在预测期内实现最高的复合年增长率。临床实验室是提供各种实验室程序的医疗机构,可帮助医生对患者进行诊断、治疗和管理。临床实验室是分子诊断产品和服务的主要用途。它拥有符合监管要求的完善设施。实验室使用不同参数的所有可能的血液分析。使用不同的仪器、试剂、方法和技术对从患者身上采集的样本进行分析和研究。这些实验室为医院、诊所和其他机构提供服务。慢性病、传染病、生活方式障碍的日益流行是促进市场增长的主要因素之一。

凝血分析仪市场(按产品)- 2022 年和 2030 年

>

区域分析

北美在凝血分析仪市场占据最大份额。在北美,美国是凝血分析仪的最大市场。该市场的增长主要是由于血液疾病发病率的增加、心房颤动 (AFib) 等心血管疾病的患病率不断上升、市场参与者的发展以及美国主要市场参与者的存在推动的。根据美国疾病控制与预防中心 (CDC) 的数据,2019 年,美国约有 183,321 份死亡证明中提到了 AFib;在其中近 26,535 例死亡中,这是主要死因。预计到 2030 年,美国将有 1210 万人患有 AFib。根据加拿大预防保健工作组的数据,加拿大心房颤动 (AFib) 的发病率每年增加 4.5%,40 岁以上人群的终生风险约为 25%。血液疾病发病率的增加可能会推动对凝血分析仪的需求。例如,根据 CDC 的数据,每 5,000 名男新生儿中就有 1 人患有 A 型血友病。每年有近 400 名婴儿出生时患有 A 型血友病。它还提到,2012 年至 2018 年期间,美国约有 33,000 名男性被诊断患有血友病。此外,大约 30 万加拿大人携带遗传性出血性疾病基因。其中十分之一(至少 30,000 名加拿大人)的症状严重到需要医疗护理。其中许多人尚未得到正确诊断。只有 10,000 名遗传性出血性疾病患者在加拿大遗传性出血性疾病综合护理诊所网络中进行了登记。

提高血液疾病意识的计划可能有利于凝血分析仪的市场增长。血友病健康教育和预防资助项目是 CDC 血液疾病部门最大的项目。疾病预防控制中心资助了旨在促进健康和预防与出血性疾病相关的并发症的项目。

因此,血液疾病的数量不断增加,心血管疾病的患病率不断上升,以及政府对预防该地区血液疾病的支持预计将在预测期内推动北美凝血分析仪市场的增长。

该报告介绍了在全球凝血分析仪市场运营的领先企业。其中包括 Abbott Laboratories、Danaher Corp、Siemens Healthcare GmbH、Thermo Fisher Scientific Inc、Sysmex Corporation、Horiba Ltd.、Nihon Kohden Corp、F. Hoffmann-La Roche Ltd、Maccura Biotechnology Co Ltd 和 Bio Group Medical System SRL。 br>
2021 年 2 月,西门子医疗 (Siemens Healthineers) 和希森美康公司 (Sysmex Corporation) 宣布续签公司针对广泛的止血产品组合的长期全球供应、分销、销售和服务协议,包括多年延期。作为协议的一部分,西门子医疗将分销新的Sysmex CN系统。

2020年7月,Sysmex宣布推出新产品——“自动凝血分析仪CN-6000和CN-3000”

公司简介

Abbott LaboratoriesDanaher CorpSiemens Healthcare GmbHThermo Fisher Scientific IncSysmex CorporationHoriba Ltd.Nihon Kohden CorpF. Hoffmann-La Roche LtdMaccura Biotechnology Co LtdBio Group Medical System SRL
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment led the Coagulation Analyzers market?

Based on product type, the clinical laboratory analyzers segment took the forefront lead in the global market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

What is meant by the Coagulation Analyzers market?

Coagulation analyzers measure blood platelet levels in a fast and simple process. The coagulation analyzer is used for measuring a coagulation pathway speed and thrombolin and thromboplastin levels in low as in a few minutes. Also, several top companies are manufacturing innovative coagulation analyzers for hemostasis testing. The Sysmex CS-2500 system is one such example that employs smartly designed technologies involving assay-based preanalytical sample-quality checks using PSI technology, automated mixing studies, automated platelet aggregation, and clot waveform analysis. Such automated processes improve efficiency, exceptional accuracy, and reliable first-run results.

What are the driving factors for the Coagulation Analyzers market across the globe?

Rising prevalence of blood disorders is a standalone factor responsible for driving the overall coagulation analyzers market growth during the forecast period.

Which test type segment held the largest revenue (US$ Mn) in the Coagulation Analyzers market?

The prothrombin time testing segment dominated the global coagulation analyzers market and accounted for the largest revenue in 2022.

Who are the key players in the Coagulation Analyzers market?

Abbott Laboratories, Danaher Corp, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corp, F. Hoffmann-La Roche Ltd, Maccura Biotechnology Co Ltd, and Bio Group Medical System SRL, among others are among the leading companies operating in the global coagulation analyzers market.

The List of Report Companies - Coagulation Analyzers Market

  1. Abbott Laboratories
  2. Danaher Corp
  3. Siemens Healthcare GmbH
  4. Thermo Fisher Scientific Inc
  5. Sysmex Corporation
  6. Horiba Ltd.
  7. Nihon Kohden Corp
  8. F. Hoffmann-La Roche Ltd
  9. Maccura Biotechnology Co Ltd
  10. Bio Group Medical System SRL

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports